Financial Year |
March 31 2023 |
Monetary Funds |
480,083,431.54 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
86,205,655.16 |
Accounts Receivable |
1,092,393,223.68 |
Advances to Suppliers |
120,271,006.09 |
Other Receivables |
207,874,110.31 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
724,064,441.22 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
18,492,846.87 |
Total Current Assets |
2,879,824,719.42 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
96,732,018.56 |
Investment Properties |
19,694,160.43 |
Fixed Assetes |
1,111,860,768.01 |
Under-construction Projects |
324,911,085.86 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
231,318,130.42 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
33,693,821.70 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
1,841,089,930.72 |
Total Assets |
4,720,914,650.14 |
Short-Term Loans |
714,929,070.00 |
Trading Financial liabilities |
-- |
Notes Payable |
355,926,624.36 |
Accounts Payable |
395,826,556.91 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
14,022,844.25 |
Taxes Payable |
12,443,595.48 |
Interest Payable |
4,312,957.42 |
Dividend Payable |
-- |
Other payables |
18,774,849.07 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
111,722,600.00 |
Other Current Liabilities |
23,184,032.24 |
Sub-Total of Current Liabilities |
1,766,268,504.20 |
Long-term Loans |
392,273,046.30 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
6,536,799.21 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
466,991,446.40 |
Total Liabilities |
2,233,259,950.60 |
Paid-In Capital(Or Share Stock) |
960,000,000.00 |
Capital Surplus |
673,122,118.62 |
Surplus Reserve |
127,745,470.69 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
728,161,982.66 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,487,654,699.54 |
Owner's Equity(Stockholder's Equity) |
2,487,654,699.54 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
4,720,914,650.14 |